CLDX Stock Analysis: Buy, Sell, or Hold?
CLDX - Celldex Therapeutics, Inc
$24.60
-0.09 (-0.36%)
▼
HOLD
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Get Alerted When CLDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: CLDX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: CLDX shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: CLDX is currently trading at $24.60, which is considered fair relative to its 30-day fair value range of $25.68 to $27.05.
Technical Outlook: Technically, CLDX is in a uptrend. The price is currently testing key support at $23.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CLDX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $53.36 (+116.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, CLDX is in a uptrend. The price is currently testing key support at $23.95. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: CLDX has a weak technical setup (25/100), with bearish trendlines and momentum suggesting caution for short-term entries. Wall Street analysts see significant upside, with an average price target of $53.36 (+116.1%). The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
FAIR
Fair Price Range
$25.68 -
$27.05
Company Quality Score
44/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
50.0%
Protect Your Profits
Holding CLDX? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 116.1% below Wall St target ($53.36)
- CAUTION: 5-day price weakness (-5.1%) - monitor closely
Fair Price Analysis
30-Day Fair Range
$25.68 -
$27.05
Current vs Fair Value
FAIR
Support & Resistance Levels
Support Level
$23.95
Resistance Level
$26.96
Current Trend
Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-5.59
Wall Street Target
$53.36
(+116.1%)
Revenue Growth (YoY)
-70.8%
Last updated: January 31, 2026 3:51 PM ET
Data refreshes hourly during market hours. Next update: 4:51 PM
Data refreshes hourly during market hours. Next update: 4:51 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CLDX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$404 | 63 BUY |
|
XENE
Xenon Pharmaceuticals Inc |
STRONG BUY
19 analysts |
$56 | 59 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
19 analysts |
$210 | 57 HOLD |
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$64 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
27 analysts |
$102 | 62 BUY |
Advanced CLDX Option Strategies
Professional options setups generated by AI based on today's CLDX price and gamma walls.
